Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma

Background: Pancreatic adenocarcinoma (PAAD) is among the most common types of cancer with a poor prognosis. Transmembrane protein 170B (TMEM170B) has been reported to suppress breast cancer proliferation, metastasis, and tumorigenesis and is related to prognosis. However, its role in PAAD and the u...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zilong, Shang, Jin, Dai, Zonglin, Yao, Yutong, Shi, Ying, Zhong, Deyuan, Liang, Yuxin, Lai, Chunyou, Yang, Qinyan, Feng, Tianhang, Huang, Xiaolun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117611/
https://www.ncbi.nlm.nih.gov/pubmed/35601487
http://dx.doi.org/10.3389/fgene.2022.848391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117611/
https://www.ncbi.nlm.nih.gov/pubmed/35601487
http://dx.doi.org/10.3389/fgene.2022.848391

Ejemplares similares